IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
Amazon Pharmacy Expands Access to New Ozempic® Pill via Same-Day Delivery, Kiosks
Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
Evolent Announces First Quarter 2026 Results
Pagaya Appoints Chief Strategy Officer Jonathan Dobres as CFO, Succeeding Evangelos Perros
FHLBank Chicago and Associated Bank Award $375,000 to Support Emerging Housing Developers
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026